Third Harmonic Bio Inc (THRD)

10:59 AM

Fierce Biotech Layoff Tracker 2025: Opthea reduces workforce by 65%; Organon lays off 93 staffers - Fierce Biotech

10:59 AM

Apr 07, 2025

Third Harmonic stock rating cut by Raymond James - MSN

Apr 07, 2025

Mar 31, 2025

Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks

Mar 31, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 29, 2025

Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks

Mar 29, 2025

Mar 29, 2025

Stifel Downgrades Third Harmonic Bio (THRD) - MSN

Mar 29, 2025

Mar 28, 2025

Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener

Mar 28, 2025

Mar 28, 2025

Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks

Mar 28, 2025

Mar 27, 2025

Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks

Mar 27, 2025

Mar 27, 2025

Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com

Mar 27, 2025

Mar 27, 2025

Third Harmonic Bio Q4 Net Income USD -13.1 Million - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 27, 2025

Mar 27, 2025

BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET - The Manila Times

Mar 27, 2025

Mar 27, 2025

Third Harmonic Bio, Inc. Announces Rise In Full Year Profit - Nasdaq

Mar 27, 2025

Mar 27, 2025

Third Harmonic's $285M War Chest Powers Phase 2 CSU Drug Development Amid Strategic Shift - Stock Titan

Mar 27, 2025

Mar 21, 2025

Third Harmonic Bio Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 21, 2025

Mar 19, 2025

2025 R&D layoffs tracker: 53,686 and counting - R&D World

Mar 19, 2025

Mar 11, 2025

Third Harmonic Bio Advances THB335 for Inflammatory Diseases - TipRanks

Mar 11, 2025

Mar 06, 2025

THB-335 counteracts cutaneous anaphylaxis in vivo - BioWorld Online

Mar 06, 2025

Mar 04, 2025

Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 04, 2025

Feb 28, 2025

Finance Watch: BridgeBio’s Oncology Spinout Reveals Go-Public Plan - Citeline

Feb 28, 2025

Feb 24, 2025

IPOs Numbers Rise In 2024, But Dwindling Returns Could Diminish Potential In 2025 - Scrip

Feb 24, 2025

Feb 23, 2025

Companies Like Third Harmonic Bio (NASDAQ:THRD) Are In A Position To Invest In Growth - Yahoo Finance

Feb 23, 2025

Feb 15, 2025

Third Harmonic Bio downgraded to Market Perform from Outperform at Raymond James - MSN

Feb 15, 2025

Feb 14, 2025

Third Harmonic Bio progresses THB335 to Phase 2 trial - MSN

Feb 14, 2025